Crisis preparedness and response

The Management Board welcomed EMA’s support to African regulators in the context of the Ebola outbreak in the Democratic Republic of Congo and Uganda caused by the Bundibugyo virus.

This is the first public health emergency where EMA’s Emergency Task Force (ETF) is engaging with the newly created African Medicines Agency (AMA) alongside participating African national regulatory authorities in its discussions with developers on possible clinical trial designs and medical countermeasures.

This engagement, grounded in the ongoing scientific collaboration between EMA and the AMA, is intended to support efficient, coordinated and timely regulatory responses to the outbreak. It also builds on the extensive experience gained through collaboration with African regulators during previous Ebola outbreaks, as well as the ongoing operationalisation of the AMA. The news announcement is available. 

Positive assessment of EMA’s activities in 2025

The…